Carbazochrome Sodium Sulfonate


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Exposure During Pregnancy 54.9%
Delirium 27.5%
Product Used For Unknown Indication 11.8%
Subdural Haematoma 3.9%
Hepatitis B 2.0%
Oesophageal Atresia 50.0%
Staphylococcal Infection 25.0%
Agranulocytosis 12.5%
Tachycardia Foetal 12.5%
Concomitant
Product Used For Unknown Indication 23.5%
Prophylaxis 18.6%
Aplastic Anaemia 13.5%
Infection Prophylaxis 6.9%
Premedication 5.7%
Prophylaxis Against Gastrointestinal Ulcer 3.0%
Antiviral Prophylaxis 2.9%
Constipation 2.8%
Antifungal Prophylaxis 2.6%
Prophylaxis Against Graft Versus Host Disease 2.6%
Bone Marrow Conditioning Regimen 2.6%
Supportive Care 2.5%
Drug Use For Unknown Indication 2.0%
Hypertension 1.9%
Haemorrhage Prophylaxis 1.8%
Prophylaxis Of Nausea And Vomiting 1.8%
Gastritis Prophylaxis 1.4%
Antibiotic Prophylaxis 1.4%
Haemostasis 1.3%
Fluid Replacement 1.2%
White Blood Cell Count Decreased 29.8%
Cardiac Failure 5.8%
Febrile Neutropenia 5.8%
Renal Impairment 5.8%
Threatened Labour 5.8%
Septic Shock 4.8%
Sepsis 3.8%
Staphylococcal Sepsis 3.8%
Vitreous Haemorrhage 3.8%
Acute Respiratory Distress Syndrome 2.9%
Mobility Decreased 2.9%
Pneumonia 2.9%
Prothrombin Time Prolonged 2.9%
Pyrexia 2.9%
Renal Failure 2.9%
Urine Output Decreased 2.9%
Venoocclusive Liver Disease 2.9%
Weight Increased 2.9%
White Blood Cell Count Increased 2.9%
Adrenal Insufficiency 1.9%

Drug Data